Growth Metrics

Repligen (RGEN) EBITDA Margin (2010 - 2026)

Repligen (RGEN) reported EBITDA Margin of 1.77% for Q1 2026, down 799.0% year-over-year from 0.25% in Q1 2025, and down 123.61% on a QoQ basis from 7.51% in Q4 2025.

Repligen (RGEN) has 17 years of EBITDA Margin data on file, last reported at 1.77% in Q1 2026.

  • Quarterly EBITDA Margin fell 799.0% year-over-year to 1.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.13% (up 1541.0% YoY) and the FY2025 annual result came in at 13.4%, up 1974.0% from the prior year.
  • EBITDA Margin eased to 1.77% in Q1 2026 per RGEN's latest filing, from 7.51% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 105.92% in Q1 2023 and bottomed at 30.9% in Q4 2024.
  • The 5-year median for EBITDA Margin is 7.51% (2025), against an average of 13.51%.
  • The widest annual swing landed in 2023, when EBITDA Margin surged 8544 bps; it then slumped 10712 bps in 2024.
  • Tracing RGEN's EBITDA Margin over 5 years: stood at 37.26% in 2022, then tumbled by 118 bps to 6.54% in 2023, then slumped by 373 bps to 30.9% in 2024, then surged by 124 bps to 7.51% in 2025, then sank by 124 bps to 1.77% in 2026.
  • Per Business Quant, the three latest RGEN EBITDA Margin figures stand at 1.77% (Q1 2026), 7.51% (Q4 2025), and 6.63% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 28.86%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 1.97%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 34.92%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 20.96%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 4.04%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 19.85%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 13.65%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.44%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 17.48%
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn -1.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.77%
Dec 31, 2025 7.51%
Sep 30, 2025 6.63%
Jun 30, 2025 33.44%
Mar 31, 2025 6.22%
Dec 31, 2024 -30.90%
Sep 30, 2024 5.92%
Jun 30, 2024 2.65%
Mar 31, 2024 -1.20%
Dec 31, 2023 -6.54%
Sep 30, 2023 7.82%
Jun 30, 2023 8.61%
Mar 31, 2023 105.92%
Dec 31, 2022 37.26%
Sep 30, 2022 11.08%
Jun 30, 2022 16.54%
Mar 31, 2022 20.48%
Dec 31, 2021 11.87%
Sep 30, 2021 15.68%
Jun 30, 2021 24.15%
Mar 31, 2021 13.91%
Dec 31, 2020 29.00%
Sep 30, 2020 20.14%
Jun 30, 2020 25.56%
Mar 31, 2020 5.57%
Dec 31, 2019 14.93%
Sep 30, 2019 -7.32%
Jun 30, 2019 9.66%
Mar 31, 2019 10.16%
Dec 31, 2018 10.62%
Sep 30, 2018 8.41%
Jun 30, 2018 -4.80%
Mar 31, 2018 8.25%
Dec 31, 2017 29.95%
Sep 30, 2017 18.30%
Jun 30, 2017 38.47%
Mar 31, 2017 13.40%
Dec 31, 2016 3.04%
Sep 30, 2016 3.42%
Jun 30, 2016 4.66%
Mar 31, 2016 14.03%
Dec 31, 2015 1.99%
Sep 30, 2015 10.13%
Jun 30, 2015 23.55%
Mar 31, 2015 -4.50%
Dec 31, 2014 -21.06%
Sep 30, 2014 -10.85%
Jun 30, 2014 8.83%
Mar 31, 2014 28.85%
Dec 31, 2013 30.45%
Sep 30, 2013 38.78%
Jun 30, 2013 28.05%
Mar 31, 2013 17.43%
Dec 31, 2012 101.81%
Sep 30, 2012 35.18%
Jun 30, 2012 -1.03%
Sep 30, 2011 7.04%
Jun 30, 2011 -0.73%
Mar 31, 2011 -34.38%
Dec 31, 2010 2.34%
Sep 30, 2010 7.21%
Jun 30, 2010 20.83%